Evir Pharma Support AB

Active
559477-6196Limited company (AB)Registered 2024UPPSALA

Key figures

1 958 000 kr+267,4%
Revenue 2025
+267,4%
Average annual growth 2024–2025
0500 k1 m1,5 m2 m20242025

Key figures

2025

Summary: Evir Pharma Support AB

What kind of company is it?

Evir Pharma Support AB (org. no. 559477-6196) is a limited company (AB). The company was registered in 2024 and has existed for 2 years. Registered seat: Uppsala. Industry according to Statistics Sweden: business and other management consultancy activities (SNI 70200).

How is the company doing financially?

Net sales in financial year 2025 were 1 958 000 kr, up 267 % on the previous year (533 000 kr). Net profit for 2025 was 606 714 kr (31,0 % of net sales). Employees in financial year 2025: 1. Net sales per employee were 1 958 000 kr. At the end of financial year 2025, total assets were 1 848 603 kr and equity 808 485 kr (equity ratio 43,7 %). The annual report for 2025 proposes a dividend of 322 400 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025

Proposed dividend 322 400 kr.

Summary of annual reports2024–2025
20242025
Sales revenue533 0001 958 000
Profit for the reporting year176 771606 714
Retained earnings of previous periods——
Total assets491 9111 848 603
Total liabilities290 1401 040 118
Total equity201 771808 485
Employees11
Proposed dividend—322 400

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.